1. capital flip benefit- adds capital buffer for africa and removes ravenswood drawndown demand
2. lse listing - europeans (and all insto investors) prefer companies with a clear alignment to portfolio - generally either regional/country specific or total scale. generally they prefer mid tier (sub 1000kozpa producers) to be in a specific region - ie africa only
london has long history of african investment - tends to have higher comfort with those operations and sovereign risks than aussies - which is the reason for listing there
pragmatically for eg gold analyst in london doesnt want to have to fly to africa for site visits - then go across to Australia - nor does a company want to pay for all the attendant expenses.
its not a must. ultimately the market has to deal with whatever portfolio a company has. but if you;re going to list in a new place ideally its better to have the kind of investment offering they prefer
most investors they see on lse would prefer a cleaner leaner africa-only story at this point - esp given ravenswood new format is still 'unproven' and is relatively small size/higher cost
this is why you dont tend to see rrl and evn's going OS. they want to avoid what happened to OCG and Kingsgate
- Forums
- ASX - By Stock
- Resolute to sell Ravenswood
@AvgJoe1. capital flip benefit- adds capital buffer for africa...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSG (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $1.543B |
Open | High | Low | Value | Volume |
40.5¢ | 40.5¢ | 37.5¢ | $22.35M | 57.19M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14881 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 668567 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.245 |
14 | 458433 | 1.240 |
12 | 312067 | 1.235 |
6 | 139692 | 1.230 |
6 | 131961 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 371388 | 17 |
1.255 | 220916 | 10 |
1.260 | 134993 | 10 |
1.265 | 104166 | 6 |
1.270 | 38032 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
RSG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online